Jeffrey Cohen
Stock Analyst at Ladenburg Thalmann
(0.36)
# 4,293
Out of 5,124 analysts
20
Total ratings
28.57%
Success rate
-27.92%
Average return
Main Sectors:
Stocks Rated by Jeffrey Cohen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HROW Harrow | Maintains: Buy | $64 → $66 | $49.91 | +32.24% | 2 | Nov 12, 2025 | |
| CELH Celsius Holdings | Maintains: Neutral | $62 → $58 | $47.75 | +21.47% | 3 | Mar 27, 2025 | |
| ECOR electroCore | Maintains: Buy | $28 → $26 | $4.55 | +471.43% | 2 | Mar 13, 2025 | |
| NUWE Nuwellis | Downgrades: Neutral | n/a | $1.81 | - | 1 | Nov 8, 2023 | |
| SABS SAB Biotherapeutics | Downgrades: Neutral | n/a | $3.75 | - | 1 | Oct 5, 2023 | |
| VERO Venus Concept | Maintains: Buy | $536 → $363 | $1.52 | +23,781.58% | 2 | Mar 28, 2023 | |
| FBIO Fortress Biotech | Initiates: Buy | $90 | $4.03 | +2,133.25% | 1 | Aug 4, 2022 | |
| OPK OPKO Health | Initiates: Buy | $7 | $1.27 | +451.18% | 1 | Jun 21, 2021 | |
| NNOX Nano-X Imaging | Initiates: Buy | $52 | $2.83 | +1,737.46% | 1 | Apr 19, 2021 | |
| TENX Tenax Therapeutics | Upgrades: Buy | n/a | $11.05 | - | 1 | May 18, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $40.52 | - | 5 | Apr 27, 2017 |
Harrow
Nov 12, 2025
Maintains: Buy
Price Target: $64 → $66
Current: $49.91
Upside: +32.24%
Celsius Holdings
Mar 27, 2025
Maintains: Neutral
Price Target: $62 → $58
Current: $47.75
Upside: +21.47%
electroCore
Mar 13, 2025
Maintains: Buy
Price Target: $28 → $26
Current: $4.55
Upside: +471.43%
Nuwellis
Nov 8, 2023
Downgrades: Neutral
Price Target: n/a
Current: $1.81
Upside: -
SAB Biotherapeutics
Oct 5, 2023
Downgrades: Neutral
Price Target: n/a
Current: $3.75
Upside: -
Venus Concept
Mar 28, 2023
Maintains: Buy
Price Target: $536 → $363
Current: $1.52
Upside: +23,781.58%
Fortress Biotech
Aug 4, 2022
Initiates: Buy
Price Target: $90
Current: $4.03
Upside: +2,133.25%
OPKO Health
Jun 21, 2021
Initiates: Buy
Price Target: $7
Current: $1.27
Upside: +451.18%
Nano-X Imaging
Apr 19, 2021
Initiates: Buy
Price Target: $52
Current: $2.83
Upside: +1,737.46%
Tenax Therapeutics
May 18, 2017
Upgrades: Buy
Price Target: n/a
Current: $11.05
Upside: -
Apr 27, 2017
Downgrades: Neutral
Price Target: n/a
Current: $40.52
Upside: -